Allogeneic hemopoietic stem cell transplantation (BMT) after IV busulfan, and cyclophosphamide (BuCy) for acute myeloid leukemia (AML) and myelodysplasia (MDS).

被引:0
|
作者
Andersson, BS
Cagnoni, P
Jones, R
Gian, V
Wingard, JR
Tarantolo, S
Kashyap, A
Forman, SJ
Hu, WH
Blume, KG
Fernandez, HF
Champlin, RE
机构
[1] Univ Colorado, Boulder, CO 80309 USA
[2] Univ Florida, Gainesville, FL 32611 USA
[3] Univ Nebraska, Lincoln, NE 68583 USA
[4] Univ Miami, Coral Gables, FL 33124 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
729
引用
收藏
页码:167A / 167A
页数:1
相关论文
共 50 条
  • [21] High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantation
    Simpson, DR
    Nevill, TJ
    Shepherd, JD
    Fung, HC
    Horsman, DE
    Nantel, SH
    Vickars, LM
    Sutherland, HJ
    Toze, CL
    Hogge, DE
    Klingemann, HG
    Naiman, SC
    Barnett, MJ
    BONE MARROW TRANSPLANTATION, 1998, 22 (03) : 259 - 264
  • [22] High incidence of extramedullary relapse of AML after busulfan/cyclophosphamide conditioning and allogeneic stem cell transplantation
    DR Simpson
    TJ Nevill
    JD Shepherd
    HC Fung
    DE Horsman
    SH Nantel
    LM Vickars
    HJ Sutherland
    CL Toze
    DE Hogge
    HG Klingemann
    SC Naiman
    MJ Barnett
    Bone Marrow Transplantation, 1998, 22 : 259 - 264
  • [23] Conditioning with busulfan and fludarabine for allogeneic haematopoietic stem cell transplantation in children with acute myeloid leukaemia: a comparison to busulfan and cyclophosphamide
    Lee, S. H.
    Cheuh, H.
    Yoo, K. H.
    Sung, K. W.
    Koo, H. H.
    Lee, J. W.
    Kim, H.
    Kang, H. J.
    Park, K. D.
    Shin, H. Y.
    Ahn, H. S.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S139 - S139
  • [24] Treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) relapsing after allogeneic hematopoietic cell transplantation (HCT).
    Chiattone, A.
    Andersson, B.
    Bashir, Q.
    Landau, D.
    Rondon, G.
    Nieto, Y.
    Al Atrash, G.
    Giralt, S.
    Champlin, R. E.
    De Lima, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [25] ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT) FOR ACUTE MYELOID-LEUKEMIA (AML)
    SCHWARZINGER, I
    HINTERBERGER, W
    SCHMIDMEIER, W
    FISCHER, M
    GEISSLER, K
    KALLINGER, W
    ALTH, G
    VOLCPLATZER, B
    HAJEKROSENMAYR, A
    LECHNER, K
    GADNER, H
    DEUTSCH, E
    BLUT, 1985, 51 (03): : 222 - 223
  • [26] Dose reduced conditioning and allogeneic stem cell transplantation in 34 patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS).
    Bornhauser, M
    Kroschinsky, F
    Ulrike, S
    Markus, S
    Eberhard, S
    Ralph, N
    Thiede, C
    Ulrich, S
    Gerhard, E
    BLOOD, 2000, 96 (11) : 780A - 780A
  • [27] Dose reduced conditioning and allogeneic stem cell transplantation in 36 patients with Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)
    Bornhäuser, M
    Schaich, M
    Schaekel, U
    Mahlberg, R
    Clemens, M
    Ehninger, G
    BONE MARROW TRANSPLANTATION, 2001, 27 : S85 - S85
  • [28] Impacts of post-transplantation cyclophosphamide treatment after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
    Namdaroglu, Sinem
    Kaya, Ali Hakan
    Batgi, Hikmettullah
    Kayikci, Omur
    Dal, Mehmet Sinan
    Iskender, Dicle
    Cakar, Merih Kizil
    Tekgunduz, Emre
    Altuntas, Fevzi
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [29] Impacts of post-transplantation cyclophosphamide treatment after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
    Sinem Namdaroglu
    Ali Hakan Kaya
    Hikmettullah Batgi
    Omur Kayikci
    Mehmet Sinan Dal
    Dicle Iskender
    Merih Kizil Cakar
    Emre Tekgunduz
    Fevzi Altuntas
    Scientific Reports, 9
  • [30] Allogeneic hematopoietic stem cell transplantation for acute leukemia, chronic leukemia, and myelodysplasia
    Popplewell, L
    Forman, SJ
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1999, 13 (05) : 987 - +